Navigation Links
Critical Access Hospital Consolidator Seeks Cost-Management Solutions with Broadlane
Date:7/16/2009

HMC/CAH Consolidated, Inc. Names Broadlane Exclusive Provider of Supply Chain Services.

Dallas (Vocus) July 16, 2009 -- Broadlane announced today through a corporate relationship agreement that HMC/CAH Consolidated, Inc., based in Kansas City, Missouri has selected Broadlane as the exclusive provider of a broad range of cost-management solutions to help manage spending for all HMC/CAH-acquired critical access hospitals.

"As the industry-leading consolidator of critical access hospitals, we are constantly seeking ways to reduce costs without sacrificing quality as we transform hospitals into modern, new facilities," said Gordon Docking, chief operating officer, HMC/CAH. "After conducting a thorough analysis, we selected Broadlane for the demonstrated cost-management results they continually deliver to their clients, utilizing supply chain best practices to generate improvements and savings."

HMC/CAH will access Broadlane's unparalleled national GPO portfolio of consumable supplies, equipment, pharmaceuticals and purchased services. Additionally, HMC/CAH will utilize OnRamp® (Broadlane's client portal) to access contract and vendor information, run reports (such as pharmacy price verification), view Broadlane news and information and download training and continuing education materials.

Broadlane's Capital Equipment Services will aid HMC/CAH as they continue to acquire critical access hospitals and replace them with state-of-the-art facilities. These Capital Equipment Services include Live Group Buys and Quote Review where price, warranty and term information is reviewed to promote accuracy of terms and pricing. Additionally, Broadlane client hospitals historically save approximately 25 percent and up to three months of research and negotiation time through participation at Broadlane Live Group Buys.    

"We are excited to welcome HMC/CAH as the newest Broadlane client," said David Ricker, chief executive officer, Broadlane. "As HMC/CAH continues to acquire and consolidate critical access hospitals, we hope to deliver the most cost-effective means to improve and modernize these facilities. We are confident that the custom solutions we developed will deliver significant process improvements and cost savings to HMC/CAH hospitals to help HMC/CAH achieve their mission of developing the premier Critical Access Hospital network in the country."

About HMC/CAH Consolidated Inc.
HMC/CAH Consolidated, Inc. desires to become an industry leading consolidator of Critical Access Hospitals (CAHs). As part of the acquisition HMC/CAH will replace the old hospital with a new state of the art facility.

Since 1982, HMC/CAH and its predecessor companies have provided consulting, development, and management services to more than 800 hospitals throughout the United States. HMC/CAH Consolidated, Inc. was formed in April 2007.

The business existing prior to the formation of HMC/CAH was formally known as Hospital Management Consulting (HMC) and was founded in 2000 to specialize in the management, operation, strategic and financial planning, and new service development for inpatient and outpatient healthcare providers.

In the past seven years, HMC and now HMC/CAH has worked with over 200 rural hospitals, 150 of which have been Critical Access Hospitals (CAHs).

HMC/CAH's engagements have included approximately 25 major hospital replacement or expansion projects. Today HMC/CAH owns seven Critical Access Hospital, and manages two others. Their growth plans project 40 owned facilities within the next five years.

About Broadlane
Broadlane is the leading cost-management company for healthcare providers, reducing cost and creating operational efficiencies for thousands of acute care hospitals, ambulatory care facilities, physician practices and other healthcare providers in the United States. Its core services include supply chain management and clinical workforce management services.

Broadlane's clients include leading providers such as Advocate Health Care, Ascension Health, Beaumont Hospitals, CHRISTUS Health, Continuum Health Partners, Kaiser Permanente, Kindred Healthcare, MedCath Corporation, New Hanover Regional Medical Center, Sisters of Charity of Leavenworth Health System, Tenet Healthcare, The Health Alliance of Greater Cincinnati, US Oncology and UMass Memorial Health Care.
The company is headquartered in Dallas with offices in Cincinnati, Detroit, Houston, New York City and Oakland. For more information, visit www.broadlane.com.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2645654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Emdeon To Collaborate With Rx Response in Critical Pharmacy Disaster Reporting
2. ICU Medical, Inc. to Acquire Hospiras Critical Care Product Line
3. MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage
4. IBM Award for Innovative Solution to Tackling Worlds Most Critical Social and Environmental Problems
5. Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap
6. Delirium in hospitalized adults: Situation critical, no relief available
7. Specialty Hospitals of America Accepts First Patients in New Long Term Critical Care Hospital Located in South East Washington
8. Pivotal White Paper Examines Retail Industrys Critical Role in Reengineering the Health Care System
9. Top Obama Administration Officials to Engage Latino Leaders on Critical Policy Issues in Los Angeles This Week
10. Kevin Niksarli, M.D. Of Newsight Laser Center, New York, N.Y. Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6/17/2009
11. Young offenders health critical to rehabilitation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Critical Access Hospital Consolidator Seeks Cost-Management Solutions with Broadlane 
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: